Published on 14 Jan 2022 on Simply Wall St. via Yahoo Finance
Are Institutions Heavily Invested In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares?
A look at the shareholders of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Companies that have been privatized tend to have low insider ownership.
BioCryst Pharmaceuticals has a market capitalization of US$2.9b, so we would expect some institutional investors to have noticed the stock. In the chart below, we can see that institutions are noticeable on the share registry. Let's take a closer look to see what the different types of shareholders can tell us about BioCryst Pharmaceuticals.
See our latest analysis for BioCryst Pharmaceuticals